0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Influenza Diagnostics Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-19G9270
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Influenza Diagnostics Market Insights and Forecast to 2028

Global Influenza Diagnostics Market Insights and Forecast to 2028

Code: QYRE-Auto-19G9270
Report
January 2022
111 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
Market Analysis and Insights: Global Influenza Diagnostics Market

The global Influenza Diagnostics market size is projected to reach US$ 3599.9 million by 2028, from US$ 2335.5 million in 2021, at a CAGR of 6.3% during 2022-2028.

North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Influenza Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Influenza Diagnostics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Influenza Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Influenza Diagnostics market.
Global Influenza Diagnostics Scope and Market Size
Influenza Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Influenza Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

RIDT
RT-PCR
Cell Culture
Others

Segment by Application

Hospitals
POCT
Others

BY COMPANY

BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 RIDT
1.2.3 RT-PCR
1.2.4 Cell Culture
1.2.5 Others
1.3 Market by Application
1.3.1 Global Influenza Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Influenza Diagnostics Market Perspective (2017-2028)
2.2 Influenza Diagnostics Growth Trends by Region
2.2.1 Influenza Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Influenza Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Influenza Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Influenza Diagnostics Market Dynamics
2.3.1 Influenza Diagnostics Industry Trends
2.3.2 Influenza Diagnostics Market Drivers
2.3.3 Influenza Diagnostics Market Challenges
2.3.4 Influenza Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Influenza Diagnostics Players by Revenue
3.1.1 Global Top Influenza Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Influenza Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Influenza Diagnostics Revenue
3.4 Global Influenza Diagnostics Market Concentration Ratio
3.4.1 Global Influenza Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Diagnostics Revenue in 2021
3.5 Influenza Diagnostics Key Players Head office and Area Served
3.6 Key Players Influenza Diagnostics Product Solution and Service
3.7 Date of Enter into Influenza Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza Diagnostics Breakdown Data by Type
4.1 Global Influenza Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Influenza Diagnostics Forecasted Market Size by Type (2023-2028)
5 Influenza Diagnostics Breakdown Data by Application
5.1 Global Influenza Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Influenza Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Influenza Diagnostics Market Size (2017-2028)
6.2 North America Influenza Diagnostics Market Size by Type
6.2.1 North America Influenza Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Influenza Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Influenza Diagnostics Market Share by Type (2017-2028)
6.3 North America Influenza Diagnostics Market Size by Application
6.3.1 North America Influenza Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Influenza Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Influenza Diagnostics Market Share by Application (2017-2028)
6.4 North America Influenza Diagnostics Market Size by Country
6.4.1 North America Influenza Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Influenza Diagnostics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Influenza Diagnostics Market Size (2017-2028)
7.2 Europe Influenza Diagnostics Market Size by Type
7.2.1 Europe Influenza Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Influenza Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Influenza Diagnostics Market Share by Type (2017-2028)
7.3 Europe Influenza Diagnostics Market Size by Application
7.3.1 Europe Influenza Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Influenza Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Influenza Diagnostics Market Share by Application (2017-2028)
7.4 Europe Influenza Diagnostics Market Size by Country
7.4.1 Europe Influenza Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Influenza Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Influenza Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Influenza Diagnostics Market Size by Type
8.2.1 Asia-Pacific Influenza Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Influenza Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Influenza Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Influenza Diagnostics Market Size by Application
8.3.1 Asia-Pacific Influenza Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Influenza Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Influenza Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Influenza Diagnostics Market Size by Region
8.4.1 Asia-Pacific Influenza Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Influenza Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Influenza Diagnostics Market Size (2017-2028)
9.2 Latin America Influenza Diagnostics Market Size by Type
9.2.1 Latin America Influenza Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Influenza Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Influenza Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Influenza Diagnostics Market Size by Application
9.3.1 Latin America Influenza Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Influenza Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Influenza Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Influenza Diagnostics Market Size by Country
9.4.1 Latin America Influenza Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Influenza Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Influenza Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Influenza Diagnostics Market Size by Type
10.2.1 Middle East & Africa Influenza Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Influenza Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Influenza Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Influenza Diagnostics Market Size by Application
10.3.1 Middle East & Africa Influenza Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Influenza Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Influenza Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Influenza Diagnostics Market Size by Country
10.4.1 Middle East & Africa Influenza Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Influenza Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Influenza Diagnostics Introduction
11.1.4 BD Revenue in Influenza Diagnostics Business (2017-2022)
11.1.5 BD Recent Developments
11.2 Abbott (Include Alere)
11.2.1 Abbott (Include Alere) Company Details
11.2.2 Abbott (Include Alere) Business Overview
11.2.3 Abbott (Include Alere) Influenza Diagnostics Introduction
11.2.4 Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2017-2022)
11.2.5 Abbott (Include Alere) Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Influenza Diagnostics Introduction
11.3.4 Roche Revenue in Influenza Diagnostics Business (2017-2022)
11.3.5 Roche Recent Developments
11.4 SIEMENS
11.4.1 SIEMENS Company Details
11.4.2 SIEMENS Business Overview
11.4.3 SIEMENS Influenza Diagnostics Introduction
11.4.4 SIEMENS Revenue in Influenza Diagnostics Business (2017-2022)
11.4.5 SIEMENS Recent Developments
11.5 Analytik Jena
11.5.1 Analytik Jena Company Details
11.5.2 Analytik Jena Business Overview
11.5.3 Analytik Jena Influenza Diagnostics Introduction
11.5.4 Analytik Jena Revenue in Influenza Diagnostics Business (2017-2022)
11.5.5 Analytik Jena Recent Developments
11.6 Quidel
11.6.1 Quidel Company Details
11.6.2 Quidel Business Overview
11.6.3 Quidel Influenza Diagnostics Introduction
11.6.4 Quidel Revenue in Influenza Diagnostics Business (2017-2022)
11.6.5 Quidel Recent Developments
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Details
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher Influenza Diagnostics Introduction
11.7.4 Thermo Fisher Revenue in Influenza Diagnostics Business (2017-2022)
11.7.5 Thermo Fisher Recent Developments
11.8 Meridian Bioscience
11.8.1 Meridian Bioscience Company Details
11.8.2 Meridian Bioscience Business Overview
11.8.3 Meridian Bioscience Influenza Diagnostics Introduction
11.8.4 Meridian Bioscience Revenue in Influenza Diagnostics Business (2017-2022)
11.8.5 Meridian Bioscience Recent Developments
11.9 BioMerieux
11.9.1 BioMerieux Company Details
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Influenza Diagnostics Introduction
11.9.4 BioMerieux Revenue in Influenza Diagnostics Business (2017-2022)
11.9.5 BioMerieux Recent Developments
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Details
11.10.2 Sekisui Diagnostics Business Overview
11.10.3 Sekisui Diagnostics Influenza Diagnostics Introduction
11.10.4 Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2017-2022)
11.10.5 Sekisui Diagnostics Recent Developments
11.11 Response Biomedical
11.11.1 Response Biomedical Company Details
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Influenza Diagnostics Introduction
11.11.4 Response Biomedical Revenue in Influenza Diagnostics Business (2017-2022)
11.11.5 Response Biomedical Recent Developments
11.12 SA Scientific
11.12.1 SA Scientific Company Details
11.12.2 SA Scientific Business Overview
11.12.3 SA Scientific Influenza Diagnostics Introduction
11.12.4 SA Scientific Revenue in Influenza Diagnostics Business (2017-2022)
11.12.5 SA Scientific Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Influenza Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of RIDT
    Table 3. Key Players of RT-PCR
    Table 4. Key Players of Cell Culture
    Table 5. Key Players of Others
    Table 6. Global Influenza Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Influenza Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Influenza Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Influenza Diagnostics Market Share by Region (2017-2022)
    Table 10. Global Influenza Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Influenza Diagnostics Market Share by Region (2023-2028)
    Table 12. Influenza Diagnostics Market Trends
    Table 13. Influenza Diagnostics Market Drivers
    Table 14. Influenza Diagnostics Market Challenges
    Table 15. Influenza Diagnostics Market Restraints
    Table 16. Global Influenza Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Influenza Diagnostics Revenue Share by Players (2017-2022)
    Table 18. Global Top Influenza Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Diagnostics as of 2021)
    Table 19. Ranking of Global Top Influenza Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Influenza Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Influenza Diagnostics Product Solution and Service
    Table 23. Date of Enter into Influenza Diagnostics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Influenza Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Influenza Diagnostics Revenue Market Share by Type (2017-2022)
    Table 27. Global Influenza Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Influenza Diagnostics Revenue Market Share by Type (2023-2028)
    Table 29. Global Influenza Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Influenza Diagnostics Revenue Share by Application (2017-2022)
    Table 31. Global Influenza Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Influenza Diagnostics Revenue Share by Application (2023-2028)
    Table 33. North America Influenza Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Influenza Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Influenza Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Influenza Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Influenza Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Influenza Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Influenza Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Influenza Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Influenza Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Influenza Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Influenza Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Influenza Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Influenza Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Influenza Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Influenza Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Influenza Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Influenza Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Influenza Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Influenza Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Influenza Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Influenza Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Influenza Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Influenza Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Influenza Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Influenza Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Influenza Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Influenza Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Influenza Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Influenza Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Influenza Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 63. BD Company Details
    Table 64. BD Business Overview
    Table 65. BD Influenza Diagnostics Product
    Table 66. BD Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
    Table 67. BD Recent Developments
    Table 68. Abbott (Include Alere) Company Details
    Table 69. Abbott (Include Alere) Business Overview
    Table 70. Abbott (Include Alere) Influenza Diagnostics Product
    Table 71. Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
    Table 72. Abbott (Include Alere) Recent Developments
    Table 73. Roche Company Details
    Table 74. Roche Business Overview
    Table 75. Roche Influenza Diagnostics Product
    Table 76. Roche Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
    Table 77. Roche Recent Developments
    Table 78. SIEMENS Company Details
    Table 79. SIEMENS Business Overview
    Table 80. SIEMENS Influenza Diagnostics Product
    Table 81. SIEMENS Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
    Table 82. SIEMENS Recent Developments
    Table 83. Analytik Jena Company Details
    Table 84. Analytik Jena Business Overview
    Table 85. Analytik Jena Influenza Diagnostics Product
    Table 86. Analytik Jena Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
    Table 87. Analytik Jena Recent Developments
    Table 88. Quidel Company Details
    Table 89. Quidel Business Overview
    Table 90. Quidel Influenza Diagnostics Product
    Table 91. Quidel Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
    Table 92. Quidel Recent Developments
    Table 93. Thermo Fisher Company Details
    Table 94. Thermo Fisher Business Overview
    Table 95. Thermo Fisher Influenza Diagnostics Product
    Table 96. Thermo Fisher Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
    Table 97. Thermo Fisher Recent Developments
    Table 98. Meridian Bioscience Company Details
    Table 99. Meridian Bioscience Business Overview
    Table 100. Meridian Bioscience Influenza Diagnostics Product
    Table 101. Meridian Bioscience Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
    Table 102. Meridian Bioscience Recent Developments
    Table 103. BioMerieux Company Details
    Table 104. BioMerieux Business Overview
    Table 105. BioMerieux Influenza Diagnostics Product
    Table 106. BioMerieux Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
    Table 107. BioMerieux Recent Developments
    Table 108. Sekisui Diagnostics Company Details
    Table 109. Sekisui Diagnostics Business Overview
    Table 110. Sekisui Diagnostics Influenza Diagnostics Product
    Table 111. Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
    Table 112. Sekisui Diagnostics Recent Developments
    Table 113. Response Biomedical Company Details
    Table 114. Response Biomedical Business Overview
    Table 115. Response Biomedical Influenza Diagnostics Product
    Table 116. Response Biomedical Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
    Table 117. Response Biomedical Recent Developments
    Table 118. SA Scientific Company Details
    Table 119. SA Scientific Business Overview
    Table 120. SA Scientific Influenza Diagnostics Product
    Table 121. SA Scientific Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
    Table 122. SA Scientific Recent Developments
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Influenza Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. RIDT Features
    Figure 3. RT-PCR Features
    Figure 4. Cell Culture Features
    Figure 5. Others Features
    Figure 6. Global Influenza Diagnostics Market Share by Application: 2021 VS 2028
    Figure 7. Hospitals Case Studies
    Figure 8. POCT Case Studies
    Figure 9. Others Case Studies
    Figure 10. Influenza Diagnostics Report Years Considered
    Figure 11. Global Influenza Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Influenza Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Influenza Diagnostics Market Share by Region: 2021 VS 2028
    Figure 14. Global Influenza Diagnostics Market Share by Players in 2021
    Figure 15. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Diagnostics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Influenza Diagnostics Revenue in 2021
    Figure 17. North America Influenza Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Influenza Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 19. North America Influenza Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 20. North America Influenza Diagnostics Market Size Share by Country (2017-2028)
    Figure 21. United States Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Influenza Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Influenza Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Influenza Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Influenza Diagnostics Market Size Share by Country (2017-2028)
    Figure 27. Germany Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Influenza Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Influenza Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Influenza Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Influenza Diagnostics Market Size Share by Region (2017-2028)
    Figure 37. China Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Latin America Influenza Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Influenza Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Influenza Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Influenza Diagnostics Market Size Share by Country (2017-2028)
    Figure 47. Mexico Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Influenza Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Influenza Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Influenza Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Influenza Diagnostics Market Size Share by Country (2017-2028)
    Figure 53. Turkey Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. BD Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
    Figure 57. Abbott (Include Alere) Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
    Figure 58. Roche Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
    Figure 59. SIEMENS Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
    Figure 60. Analytik Jena Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
    Figure 61. Quidel Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
    Figure 62. Thermo Fisher Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
    Figure 63. Meridian Bioscience Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
    Figure 64. BioMerieux Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
    Figure 65. Sekisui Diagnostics Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
    Figure 66. Response Biomedical Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
    Figure 67. SA Scientific Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

Global Vaccine Temperature Monitoring System Market Insights Forecast to 2028
Global Vaccine Temperature Monitoring System Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-10F7540
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Nelfinavir Market Insights Forecast to 2028
Global Nelfinavir Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-25I7469
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Vancomycin Market Insights and Forecast to 2028
Global Vancomycin Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-20N7760
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Hepatitis B Human Immunoglobulin Market Insights and Forecast to 2028
Global Hepatitis B Human Immunoglobulin Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-22V7718
Tue May 03 00:00:00 UTC 2022

Add to Cart